Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 3
1975 1
1976 1
1977 1
1979 2
1983 2
1984 3
1985 2
1986 2
1987 6
1988 8
1989 4
1990 3
1991 6
1992 9
1993 10
1994 3
1995 8
1996 5
1997 8
1998 8
1999 7
2000 4
2001 7
2002 4
2003 5
2004 5
2005 5
2006 7
2007 4
2008 6
2009 7
2010 6
2011 13
2012 5
2013 15
2014 7
2015 14
2016 12
2017 9
2018 8
2019 4
2020 2
2021 4
2022 3
2023 4
2024 5
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

250 results

Results by year

Filters applied: . Clear all
Page 1
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab.
Serafini MS, Cavalieri S, Licitra L, Pistore F, Lenoci D, Canevari S, Airoldi M, Cossu Rocca M, Strojan P, Kuhar CG, Merlano M, Perrone F, Vingiani A, Denaro N, Perri F, Argiris A, Gurizzan C, Ghi MG, Cassano A, Allegrini G, Bossi P, De Cecco L. Serafini MS, et al. Among authors: canevari s. J Immunother Cancer. 2024 Jan 30;12(1):e007823. doi: 10.1136/jitc-2023-007823. J Immunother Cancer. 2024. PMID: 38290766 Free PMC article. Clinical Trial.
Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial.
Spicer J, Basu B, Montes A, Banerji U, Kristeleit R, Miller R, Veal GJ, Corrigan CJ, Till SJ, Figini M, Canevari S, Barton C, Jones P, Mellor S, Carroll S, Selkirk C, Nintos G, Kwatra V, Funingana IG, Doherty G, Gould HJ, Pellizzari G, Nakamura M, Ilieva KM, Khiabany A, Stavraka C, Chauhan J, Gillett C, Pinder S, Bax HJ, Josephs DH, Karagiannis SN. Spicer J, et al. Among authors: canevari s. Nat Commun. 2023 Jul 25;14(1):4180. doi: 10.1038/s41467-023-39679-9. Nat Commun. 2023. PMID: 37491373 Free PMC article. Clinical Trial.
Axl in ovarian cancer: a step forward for clinical breakthrough?
Sensi M, Canevari S, Tomassetti A. Sensi M, et al. Among authors: canevari s. Oncotarget. 2016 Dec 6;7(49):80105-80106. doi: 10.18632/oncotarget.13457. Oncotarget. 2016. PMID: 27876698 Free PMC article. No abstract available.
Targeting folate receptor alpha for cancer treatment.
Cheung A, Bax HJ, Josephs DH, Ilieva KM, Pellizzari G, Opzoomer J, Bloomfield J, Fittall M, Grigoriadis A, Figini M, Canevari S, Spicer JF, Tutt AN, Karagiannis SN. Cheung A, et al. Among authors: canevari s. Oncotarget. 2016 Aug 9;7(32):52553-52574. doi: 10.18632/oncotarget.9651. Oncotarget. 2016. PMID: 27248175 Free PMC article. Review.
Choline Metabolism Alteration: A Focus on Ovarian Cancer.
Bagnoli M, Granata A, Nicoletti R, Krishnamachary B, Bhujwalla ZM, Canese R, Podo F, Canevari S, Iorio E, Mezzanzanica D. Bagnoli M, et al. Among authors: canevari s. Front Oncol. 2016 Jun 22;6:153. doi: 10.3389/fonc.2016.00153. eCollection 2016. Front Oncol. 2016. PMID: 27446799 Free PMC article. Review.
Ovarian carcinoma therapy with monoclonal antibodies.
Canevari S, Miotti S, Bottero F, Valota O, Colnaghi MI. Canevari S, et al. Hybridoma. 1993 Oct;12(5):501-7. doi: 10.1089/hyb.1993.12.501. Hybridoma. 1993. PMID: 8300122 Review. No abstract available.
Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities.
Lenoci D, Resteghini C, Serafini MS, Pistore F, Canevari S, Ma B, Cavalieri S, Alfieri S, Trama A, Licitra L, De Cecco L. Lenoci D, et al. Among authors: canevari s. Transl Res. 2024 Mar;265:1-16. doi: 10.1016/j.trsl.2023.10.004. Epub 2023 Nov 8. Transl Res. 2024. PMID: 37949350 Free article.
Dietary intervention for tertiary prevention in head and neck squamous cell carcinoma survivors: clinical and translational results of a randomized phase II trial.
Cavalieri S, Bruno E, Serafini MS, Lenoci D, Canevari S, Lopez-Perez L, Hernandez L, Mariani L, Miceli R, Gavazzi C, Pasanisi P, Rosso E, Cordero F, Bossi P, Golusinski W, Dietz A, Strojan P, Fuereder T, De Cecco L, Licitra L. Cavalieri S, et al. Among authors: canevari s. Front Oncol. 2024 Jan 4;13:1321174. doi: 10.3389/fonc.2023.1321174. eCollection 2023. Front Oncol. 2024. PMID: 38239654 Free PMC article.
miRNA control of apoptotic programs: focus on ovarian cancer.
Mezzanzanica D, Canevari S, Cecco LD, Bagnoli M. Mezzanzanica D, et al. Among authors: canevari s. Expert Rev Mol Diagn. 2011 Apr;11(3):277-86. doi: 10.1586/erm.11.1. Expert Rev Mol Diagn. 2011. PMID: 21463237 Review.
250 results